Also people have sometimes been quick to denigrate the value of Acromegaly- but actually the main competitor Acromegaly drug is worth $1 billy annually, and MS main competitor is $1.6 billy annually.
So I really don't think Acromegaly is anything to be shunned in terms of market potential. Anyone looking for more sexy should be doing a different web search I think.
Keeping in mind I suspect we have a better product in the pipeline (based on available data) for both MS and Acromegaly than anything else available in terms of dosage efficacy and cost- together, this is an outrageously strong market potential. Still have Asthma, bone marrow an cancer to go!
- Forums
- ASX - By Stock
- PER
- today
today , page-30
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
Add PER (ASX) to my watchlist
|
|||||
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.00M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 80000 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 178000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 80000 | 0.070 |
1 | 13600 | 0.069 |
3 | 34205 | 0.068 |
3 | 224490 | 0.067 |
1 | 15000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 178000 | 2 |
0.075 | 13371 | 1 |
0.078 | 75476 | 2 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
Last trade - 07.00am 02/08/2024 (20 minute delay) ? |
Featured News
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
PER (ASX) Chart |
Day chart unavailable